Column Group’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

Column Group’s Portfolio EFTR Stock Details EFTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-161,049	Closed	-$2.42M	–	7
2023 Q3	$2.42M	Sell	161,049 -11,324	-7%	-$197K	1.6%	7
2023 Q2	$3.58M	Hold	172,373	–	–	1.39%	7
2023 Q1	$1.52M	Hold	172,373	–	–	0.55%	7
2022 Q4	$1.84M	Hold	172,373	–	–	0.61%	7
2022 Q3	$2.46M	Hold	172,373	–	–	0.55%	7
2022 Q2	$6.12M	Hold	172,373	–	–	1.3%	7
2022 Q1	$17.3M	Hold	172,373	–	–	3.2%	7
2021 Q4	$35.7M	Hold	172,373	–	–	4.85%	7
2021 Q3	$60.5M	Buy	+172,373	New	+$55.6M	6.89%	6

Other funds holding EFTR

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Parallel Advisors San Francisco, California $5.55B AUM 17.89% 1-Year Est. Return

Blackstone Inc New York $24.2B AUM 26.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sonora Investment Management Group Tucson, Arizona $1.41B AUM 20.58% 1-Year Est. Return

Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return